Skip to content

Immune

Thymulin

Also called FTS, Serum thymic factor

InjectableEvidence CEvery other day
Half-life
0.5hours
Typical vial
5 / 10mg
Research amounts
200–500mcg

per administration

Common schedule
Every other day
Animal or lab only

Only animal or lab studies exist — no human study has set an amount.

Work out your draw

These numbers are a starting point — change any of them.

3 mL cartridge · 300 units loaded12units dialled
Concentration
1.67mg/mL
Volume per draw
0.12mL
Units to dial
12
Doses per cartridge
25

Vial label

Copy this into your label printer.

Published research contexts for Thymulin describe 200500 mcg per administration. Descriptive only, not a recommendation.

A zinc-bound nonapeptide cleared quickly; human PK is thin and estimates are rough.

Evidence is preclinical — largely rodent and cell work on the zinc-dependent nonapeptide — and no human study fixes an amount or schedule. The figure in circulation is community-derived, not trial-established, so no schedule table is shown.

Modelled level — every other day

1× is the peak after a single dose.

Steady-state peak
1.00× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
3hours

About five half-lives

Administrations
3.5/ week

Averaged over two weeks

Where these numbers come from

  • Thymulin / FTS preclinical literatureZinc-dependent nonapeptide studied mostly in rodent and cell models; human injectable amounts are extrapolated, not trial-established.

Next steps